Slope, the only end-to-end, vendor-agnostic platform for managing biospecimens and lab kits, and CellCarta, a leading global contract research organization (CRO), today announced they have formalized ...

Slope is the only end-to-end, vendor-agnostic platform for managing biospecimens and clinical inventory across the entire clinical research ecosystem. Trusted by 2,200+ sites in 23+ countries, Slope ...

NEW YORK, Jan. 29, 2026 /PRNewswire/ -- Legacy today announced they're offering the first at-home semen analysis to deliver a complete clinical motility profile, addressing a long-standing diagnostic ...

The Food and Drug Administration (FDA) has begun 2026 with a clear signal to the direct‑to‑consumer testing industry: self‑collection devices ...

The renewed and expanded agreements provide improved commercial conditions, including more competitive pricing, optimized ...

Strong Buy reiterated with a €8.37 target price following the 21 January 2026 Flash; last close on 22 January 2026: ...

The U.S. FDA’s Center for Biologics Evaluation and Research posted four warning letters to makers of HIV sample collection kits, an example of a shift in FDA enforcement in the IVD space that is still ...

With three new partnerships, 10x Genomics signals a move beyond research tools toward clinical diagnostics using its single-cell and spatial biology platforms.

The market for microbiome sample preparation technology presents opportunities driven by demand for personalized medicine, ...

Self-collection means swabbing your vagina to get a sample of cells to test in the lab. In this case, the sample is used to ...

Pantene is back in Alix Earle’s shower with Pantene’s Abundant & Strong 3-step system for stronger, fuller hair—and a limited ...

At-home kits that allow women to collect their own samples for HPV testing have been shown to improve cervical cancer screening rates. But some women lack confidence in their ability to complete the ...